What is inflammatory bowel disease?
In addition to a personalized approach to optimize current and investigational therapies, the Northwestern Medicine Inflammatory Bowel Disease (IBD) Center provides a collaborative team effort between gastroenterologists, colorectal surgeons, specialized nurses and nurse practitioners, state-of-the-art diagnostics and nutritional and behavioral support.
Minimally invasive surgery is the norm and an expanding list of clinical trials are available within the Northwestern Medicine IBD program.
The Inflammatory Bowel Disease Program at Northwestern Memorial Hospital provides specialized care for patients diagnosed with inflammatory bowel disease (Crohn disease and ulcerative colitis). We are also involved with research that leads to better understanding of the diseases, better treatments and eventually better quality of life.
The IBD Program uses a personalized approach to optimize well-known current and investigational therapies and strategies to great patients. Our expert IBD specialists* work in close collaboration with other healthcare professionals to provide comprehensive care. These include:
- Specialized nurses
- Pathologists and radiologists
- Dermatologists and wound care (stoma) specialists
We have great expertise in this disease and its symptoms, along with access to the most effective and current medications and treatments. In addition, we are involved in leading-edge research to improve knowledge of inflammatory bowel disease and improve the quality of our patients' life.
The IBD Program provides seamless transition of care from pediatric to adult and take care of other healthcare issues related to Crohn disease and ulcerative colitis, such as colon cancer screening, stoma care and helping patients cope with the stress and psychological issues often associated with chronic disease.
The Northwestern Medicine IBD Program has been strengthened by the addition of Stephen Hanauer, MD, an international expert on the treatment of ulcerative colitis and Crohn disease. Dr. Hanauer brings more than 30 years of experience in leading an integrated, multi-specialty approach to the treatment of ulcerative colitis and Crohn disease.
Leonard Baidoo, MD, an expert in the management of complex IBC (Crohn and ulcerative colitis) cases and the use of novel medications and strategies has been appointed as the clinical director of the Northwestern Medicine IBD program. He is very active in medical education, teaching medical students, residents and fellows, as well as patients and their caregivers.
Emmanuelle Bellaguarda, MD, is a gastroenterologist who specializes in the diagnosis and management of IBD (Crohn disease and ulcerative colitis). She is also interested in clinical trials and teaching.
Adam C. Stein, MD, specializes in the treatment of a variety of different digestive disorders, with a focus on small bowel disease (such as small bowel Crohn disease, high ostomy output, short bowel syndrome, intestinal failure and celiac disease) as well as nutrition and IBD.
Laura H. Yun, MD, cares for patients with inflammatory bowel and also has an interest in women’s health issues in gastroenterology.
- Biological Treatments
- Clinical Trials
- Cognitive Behavioral Therapy
- Diagnostic Innovation for the Treatment of Bowel Disorders
- Dietary/Nutritional Support
- Minimally Invasive Surgeries
- Personalize Treatment Approaches to IBD
- Steroid-sparing Therapies
In the spirit of keeping you well-informed, the individual(s) identified are neither agents nor employees of Northwestern Memorial HealthCare or any of its affiliate organizations. They have selected our facilities as places where they want to treat and care for their private patients.